CRYSTALEST
Esteve Pharmaceuticals, S.a.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79354642 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Timeline
| 2022-09-08 | Application Filed |
| 2022-11-10 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2022-11-10 | Status: Live/Pending |
| 2022-11-14 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  ESTEVE PHARMACEUTICALS, S.A. |
| Address | TORRE ESTEVE, Passeig de la Zona Franca, 109, 4a pl. E-08038 Barcelona ES |
| Legal Entity Type | Société Anonyme (sa) |
| Legal Entity State | ES |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0421 | Research relating to technology; design and development of medical technology; medical and pharmacological research services; scientific and technological services |
| GS0421 | Research in the field of chemicals, pharmacological and scientific laboratory technology; design and development of medical technology in the field of medical devices and manufacture of chemical pharmaceuticals; medical and pharmacological research services; scientific and technological services, namely, research and design in the field of medical devices and manufacture of chemical pharmaceuticals |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-11-10 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-11-14 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2022-11-18 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2023-06-22 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2023-06-24 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-06-25 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2023-08-01 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-08-01 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2023-08-21 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-12-15 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-12-15 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-12-16 | 12 TEME I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2024-01-17 | 13 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2024-01-17 | 14 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2024-01-17 | 15 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2024-01-17 | 16 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-01-17 | 17 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-01-31 | 18 NONP E:E-Mail |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-02-01 | 19 NPUB E:E-Mail |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-02-01 | 20 NPUB E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2024-02-07 | 21 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-02-07 | 22 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2024-02-20 | 23 PUBO A:Allowance for Publication |
| NOTIFICATION PROCESSED BY IB | 2024-02-26 | 24 GPNX P: |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-03-04 | 25 NPUB E:E-Mail |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2024-04-10 | 26 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-04-10 | 27 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2024-04-29 | 28 OPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2024-05-07 | 29 R.PR A:Allowance for Publication |
| NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-05-07 | 30 NRCC E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 